Company intelligence / Profile preview

Peptide Pro

Tennessee, United Statespeptide-products.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Peptide Pro supplies high-purity, pre-synthesized peptides (>98% purity) with certificates of analysis. Products are intended solely for laboratory research and are not FDA-approved or suitable for human/veterinary use. The company offers bulk order discounts and international shipping. No clinical results as it does not conduct clinical trials.

Modalities: Synthetic peptides for research use
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Peptide Pro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptide Pro.

Explore the full profile